謝逸憲Yi-Hsien Hsieh林啟瑞Chi-Jui Lin醫學研究所2026-10-292021-01-2020212021-01-12https://handle.ncl.edu.tw/11296/gpwr97https://scholars.csmu.edu.tw/handle/123456789/36587腎臟惡性腫瘤發生率約0.06%,佔全部癌症發生率的1.29%,且每年約以 2% 的速度攀升中,而腎臟細胞癌(Renal cell carcinoma, RCC)是最常見的腎臟惡性腫瘤,約占全部的85% ,而其中20–30%的RCC患者會有癌細胞轉移現象。白花前胡素B (Praeruptorin B)是一種傘形科植物白花前胡Peucedanum praeruptorum Dunn乾燥根的成分之一,研究發現白花前胡素B具有許多藥物活性功能,包括抗腫瘤、抗發炎及解熱等。然而針對腎臟癌與白花前胡素B之間的相互作用機制仍不清楚。單一癌症的侵襲與細胞間轉移將明顯增加病人的死亡率,本研究目的是深入探討白花前胡素B抑制人類腎臟細胞癌的轉移機轉,以及相關訊息傳遞機制。利用MTT assay實驗發現,白花前胡素B濃度於小於30 µM作用24小時,對人類腎臟細胞癌細胞株(786-O和ACHN)沒有明顯影響。進一步研究指出,白花前胡素B會藉由抑制mRNA及組織蛋白酶C (CTSC) 與 組織蛋白酶V (CTSV)的表現,來抑制癌細胞的轉移及侵襲的能力。然而透過西方墨點法分析顯示,白花前胡素B會降低一些磷酸化蛋白質的表現量,如p-epidermal growth factor receptor (EGFR), p-mitogen-activated protein kinase kinase (MEK)及p-extracellular signal-regulated kinases(ERK),進而抑制腎臟細胞癌的侵襲與轉移。本研究為首次證實白花前胡素B可降低CTSC和CTSV的蛋白表現量,進一步抑制人類腎臟細胞癌轉移能力的作用機轉,未來可發展成臨床上治療腎臟細胞癌和對抗癌細胞侵襲的新興藥物。The incidence of renal malignant tumors is about 0.06%, accounting for 1.29% of all cancers, with the incidence rate rising by about 2% each year. Renal cell carcinoma (RCC) is the most common renal malignant tumor, accounting for nearly 85% of all cases. Praeruptorin B (Pra-B) is an ingredient of the dry root of Peucedanum praeruptorum Dunn, a plant of the Umbelliferae family. Research has discovered that Pra-B has several biological activities, including anti-tumor and anti-inflammatory activity. However, the mechanism of interactions between RCC and Pra-B remains unclear. The invasion and metastasis of cancer cells drastically increases mortality. The study investigated the mechanism of Pra-B inhibiting metastasis of human renal cell carcinoma and the relevant signal transduction mechanisms. Using MTT assay, we found that a 24-hour treatment of Pra-B at less than 30 µM showed no apparent effects on human renal cell carcinoma cell lines (786-O and ACHN). Further study indicated that Pra-B inhibits cancer cell metastasis by downregulating mRNA and the expression of cathepsin C (CTSC) and cathepsin V (CTSV). However, Western blot analysis indicated that Pra-B suppresses the expression of certain phosphorylated proteins, such as p-epidermal growth factor receptor (EGFR), p-mitogen-activated protein kinase kinase (MEK), and p-extracellular signal-regulated kinases(ERK), thereby inhibiting the metastasis of renal cell carcinoma. The present study provides evidence for the first time that praeruptorin B (Pra-B) downregulates the protein expression of CTSC and CTSV, which in turn inhibits the mechanism of human renal cell carcinoma metastasis. Based on this finding, novel clinical treatments against renal cell carcinoma and cancer metastasis may be developed in the future.腎臟細胞癌白花前胡素轉移組織蛋白酶表皮生長因子受體Renal cell carcinomaPraeruptorinmetastasiscathepsinEGFR探討白花前胡素B抑制人類腎臟細胞癌轉移作用經由抑制組織蛋白酶C和組織蛋白酶V表現thesis